PMO Interview with the Innovator Series: Volume 7
Video Categories: PMO Interview with the Innovator Series
Alexander Bastian speaks about the need for a sustainable model of pricing as related to cancer treatments and drug development. He talks about indication-based pricing or tumor-based pricing—says that is compelling, but not necessarily possible in the US.
Hear Dr. Mesa discuss options available for individual patients who have failed hydroxyurea polycythemia vera.Supported through funding from Incyte